Virtus ETF Advisers LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,877
-42.0%
19,835
-9.1%
0.04%
-40.6%
Q2 2023$108,411
+67.9%
21,813
+66.9%
0.06%
+77.8%
Q1 2023$64,571
-43.3%
13,071
-27.8%
0.04%
-39.0%
Q4 2022$113,830
-8.2%
18,097
+57.9%
0.06%
+20.4%
Q3 2022$124,000
-4.6%
11,462
+0.7%
0.05%
+2.1%
Q2 2022$130,000
+31.3%
11,383
+4.9%
0.05%
+9.1%
Q1 2022$99,000
-42.1%
10,848
-5.6%
0.04%
-32.3%
Q4 2021$171,000
-20.5%
11,487
+37.1%
0.06%
-31.6%
Q3 2021$215,000
-6.5%
8,379
-5.0%
0.10%0.0%
Q2 2021$230,000
-39.2%
8,817
-17.8%
0.10%
-40.6%
Q1 2021$378,000
+42.1%
10,721
+1.8%
0.16%
+45.5%
Q4 2020$266,000
-7.3%
10,536
+38.4%
0.11%
-27.2%
Q3 2020$287,000
-22.4%
7,611
-12.0%
0.15%
-13.7%
Q2 2020$370,000
+43.4%
8,650
-34.9%
0.18%
+65.1%
Q1 2020$258,000
-34.7%
13,279
-12.7%
0.11%
+63.1%
Q4 2019$395,000
+51.9%
15,214
+59.3%
0.06%
+25.0%
Q3 2019$260,000
-4.1%
9,552
-5.3%
0.05%
-8.8%
Q2 2019$271,00010,0840.06%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders